Skip to main content

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
235,659
Value
$91.1M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026235,659$91.1M<0.1%−209,798−47.1%ReducedHolders
Q1 2026445,457$130.4M0.1%−8,494−1.9%ReducedHolders
Q4 2025453,951$159.1M0.1%+252,163+125.0%AddedHolders
Q3 2025201,788$65.2M0.1%−131,815−39.5%ReducedHolders
Q2 2025333,603$129.8M0.1%−76,132−18.6%ReducedHolders
Q1 2025409,735$178.2M0.1%−9,418−2.2%ReducedHolders
Q4 2024419,153$154.6M0.1%+205,491+96.2%AddedHolders
Q3 2024213,662$111.1M0.1%−157,738−42.5%ReducedHolders
Q2 2024371,400$201.2M0.2%+23,324+6.7%AddedHolders
Q1 2024348,076$180.5M0.2%+36,370+11.7%AddedHolders
Q4 2023311,706$147.0M0.3%+55,250+21.5%AddedHolders
Q3 2023256,456$111.7M0.2%+19,054+8.0%AddedHolders
Q2 2023237,402$105.5M0.2%+54,451+29.8%AddedHolders
Q1 2023182,951$84.1M0.2%+103,542+130.4%AddedHolders
Q4 202279,409$40.7M0.1%+43,436+120.7%AddedHolders
Q3 202235,973$16.3M<0.1%−84,115−70.0%ReducedHolders
Q2 2022120,088$58.0M0.1%+45,608+61.2%AddedHolders
Q1 202274,480$36.6M0.1%−67,252−47.5%ReducedHolders
Q4 2021141,732$65.7M0.2%+47,643+50.6%AddedHolders
Q3 202194,089$35.1M0.1%−98,565−51.2%ReducedHolders
Q2 2021192,654$73.6M0.1%+151,375+366.7%AddedHolders
Q1 202141,279$14.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.